Avinger News

Avinger to Announce First Quarter 2024 Results on May 15, 2024

REDWOOD CITY, CA / ACCESSWIRE / May 7, 2024 / Avinger, Inc. , a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and

AccesswireMay 7 08:15 ET

Avinger Files to Sell 2.05M Shares for Holders

Seeking AlphaApr 3 17:42 ET

Avinger (AVGR) Upgraded to Buy: What Does It Mean for the Stock?

Yahoo FinanceMar 25 12:00 ET

Avinger Inc. on the Brink: The High Stakes of Navigating Chapter 11 Bankruptcy

TipRanksMar 22 02:00 ET

Express News | HC Wainwright & Co. Reiterates Buy on Avinger, Maintains $5 Price Target

Moomoo 24/7Mar 21 11:23 ET

Avinger's Strategic Growth and Financial Outlook: A Buy Rating From Swayampakula Ramakanth

TipRanksMar 21 11:05 ET

Earnings Call Summary | Avinger(AVGR.US) Q4 2023 Earnings Conference

The following is a summary of the Avinger, Inc. (AVGR) Q4 2023 Earnings Call Transcript:Financial Performance:No specific financial performance points provided for Avinger, Inc. (AVGR) Q4 2023 Earning

moomoo AIMar 20 18:10 ET · Conference Call

12 Health Care Stocks Moving In Wednesday's After-Market Session

GainersXTL Biopharmaceuticals (NASDAQ:XTLB) shares moved upwards by 13.9% to $2.71 during Wednesday's after-market session. The market value of their outstanding shares is at $14.7 million. Leap Thera

BenzingaMar 20 17:34 ET

Express News | Avinger Q4 2023 GAAP EPS $(3.93), Sales $1.906M Miss $2.521M Estimate

Moomoo 24/7Mar 20 16:10 ET

Earnings Flash (AVGR) AVINGER Posts Q4 Revenue $1.9M, Vs. Street Est of $2.52M

04:09 PM EDT, 03/20/2024 (MT Newswires) -- Earnings Flash (AVGR) AVINGER Posts Q4 Revenue $1.9M, vs. Street Est of $2.52M

MT NewswiresMar 20 16:09 ET

Avinger Reports Fourth Quarter and Full Year 2023 Results

New Strategic Partnership Provides Funding to Support U.S. Growth Initiatives and Coronary Product Development, Opens New Pathway for Sales in AsiaREDWOOD CITY, CA / ACCESSWIRE / March 20, 2024 / Avin

AccesswireMar 20 16:05 ET

Notable Earnings After Wednesday's Close

Seeking AlphaMar 19 17:35 ET

Avinger Q4 Earnings Preview

Seeking AlphaMar 19 17:35 ET

Avinger to Announce Full Year 2023 Results on March 20, 2024

REDWOOD CITY, CA / ACCESSWIRE / March 12, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system f

AccesswireMar 12 09:00 ET

Avinger Is Maintained at Buy by HC Wainwright & Co.

Avinger Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMar 8 10:29 ET

Strategic Partnership Boosts Avinger's Market Opportunities: A Buy Rating With a $5.00 Price Target

TipRanksMar 8 10:25 ET

Express News | HC Wainwright & Co. Maintains Buy on Avinger, Maintains $5 Price Target

Moomoo 24/7Mar 8 10:18 ET

Avinger Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/08/2024 69.49% HC Wainwright & Co. $5 → $5 Maintains Buy 11/13/2023 69.49% HC Wainwright & Co. $1.6 → $

BenzingaMar 8 10:17 ET

BREA, MSAI and APM Among Pre-market Losers

Seeking AlphaMar 8 08:40 ET

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersAinos (NASDAQ:AIMD) shares increased by 144.6% to $2.74 during Friday's pre-market session. The company's market cap stands at $12.8 million. Psyence Biomedical (NASDAQ:PBM) stock moved upwards

BenzingaMar 8 08:09 ET